Roth/MKM raises Nlight stock price target on directed energy focus

LASR is becoming a cleaner defense-technology compounder, but the market is already pricing in a near-perfect execution path. The key second-order effect is that the company’s exit from lower-margin legacy markets should mechanically improve mix, but it also removes a stabilizing revenue base, making the equity more sensitive to program timing, budget slippage, and quarter-to-quarter contract cadence. In other words, the multiple can stay elevated only if backlog converts without a meaningful pause between HELSI-2 and the next tranche of awards.

The most important catalyst is not the current quarter itself, but whether the company can prove that directed-energy demand is becoming a repeatable procurement lane rather than a one-off program win. If new awards arrive in the next 2-3 quarters, the market may re-rate LASR as a platform supplier with multi-year visibility; if not, the stock likely transitions from story-driven momentum to valuation scrutiny. Defense revenue concentration also creates a hidden dependency on a small set of primes and budget holders, so any delay in appropriations or program reviews would hit the stock disproportionately versus broader defense peers.

The contrarian setup is that consensus is treating the defense narrative as structurally underpenetrated, but the stock’s run already discounts a lot of “future TAM” optimism. The better risk/reward may be in relative value rather than outright long exposure: LASR can outperform if program flow remains strong, but the bar for upside surprises is now materially higher than the bar for disappointment. If the first quarter marks a low point as expected, the stock can still work on a 3-6 month horizon; however, absent fresh contract catalysts, the near-term upside is probably more limited than the recent price action implies.